AMN Healthcare Services, Inc. (AMN)
$
24.46
+0.89 (3.64%)
Key metrics
Financial statements
Free cash flow per share
6.6839
Market cap
934.4 Million
Price to sales ratio
0.3132
Debt to equity
1.1971
Current ratio
1.0900
Income quality
7.9010
Average inventory
0
ROE
-0.1766
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
AMN Healthcare Services, Inc. provides comprehensive healthcare workforce solutions and staffing services to hospitals and healthcare facilities across the United States, operating through three distinct segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment specializes in travel nurse staffing, rapid response nurse staffing, labor disruption, allied staffing, and local staffing, complemented by revenue cycle solutions. Meanwhile, the Physician and Leadership Solutions segment focuses on locum tenens staffing, interim healthcare leadership staffing, executive search, and physician permanent placement solutions. Additionally, the Technology and Workforce Solutions segment offers a variety of services, including language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also caters to the needs of allied health professionals such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. With notable financial performance, the company earned an interest income of $0.00 showcasing its financial investments. The total costs and expenses for the company are $3,086,454,000.00 reflecting its overall spending, while it incurred an income tax expense of -$25,595,000.00 indicating its tax obligations. The diluted EPS is -$3.85 accounting for potential share dilution, and the company's stock is identified with the symbol 'AMN' in the market. Investors watching the stock may find it affordable at $24.31 making it suitable for budget-conscious individuals. The stock has a high average trading volume of 952,143.00 indicating strong liquidity within the market. With a market capitalization of $934,389,122.00 the company is classified as a small-cap player, positioning it uniquely in the investment landscape. As a key player in the Medical - Care Facilities industry, AMN Healthcare contributes significantly to the overall market landscape, while also belonging to the Healthcare sector, driving innovation and growth within healthcare solutions.
Analysts predict AMN Healthcare Services, Inc. stock to fluctuate between $22.47 (low) and $70.07 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-04-01, AMN Healthcare Services, Inc.'s market cap is $934,389,122, based on 38,200,700 outstanding shares.
Compared to Eli Lilly & Co., AMN Healthcare Services, Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy AMN Healthcare Services, Inc. (AMN) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AMN. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $2,983,781,000 | EPS: -$3.85 | Growth: -171.56%.
Visit https://www.amnhealthcare.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $129.12 (2021-12-27) | All-time low: $22.47 (2024-12-23).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
After a contextually positive Q4, shares continue to trade at an attractive valuation. Recent demand trends and commentary increasingly suggest demand is finding a stabilization point. Macro and M&A risks remain, but today's price offers an attractive IRR, all things considered.
seekingalpha.com
AMN Healthcare is poised for revenue growth due to new remote language interpretation systems and a shift in U.S. age demographics. The company's innovative solutions like WorkWise and ShiftWise Flex enhance efficiency, supporting robust financial performance and a higher target stock price. AMN benefits from the increasing number of insured individuals in the U.S., driving national healthcare expenditures and potential revenue growth.
seekingalpha.com
In Q4 2024 AMN Healthcare posted meaningful sequential revenue growth for the first time in 2 years, suggesting its cyclical decline might be coming to an end. A variety of indicators shows stabilisation in the market, but an upward inflection doesn't seem imminent. Long-term growth and margin drivers like platformization and a larger tech segment are intact, but acquisitions are on hold due to high debt.
zacks.com
AMN, CABGY and BNPQY have been added to the Zacks Rank #5 (Strong Sell) List on February 25, 2025.
zacks.com
AMN Healthcare's dismal results in the majority of its segments led to a soft overall fourth-quarter performance.
seekingalpha.com
AMN Healthcare Services, Inc. (NYSE:AMN ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Randall Reese - Senior Director of Investor Relations and Strategy Cary Grace - President and Chief Executive Officer Brian Scott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Jasper Bibb - Truist Securities, Inc. A.J. Rice - UBS Investment Bank Jeffrey Silber - BMO Capital Markets Joanna Gajuk - Bank of America Merrill Lynch Mark Marcon - Robert W.
zacks.com
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $1.32 per share a year ago.
zacks.com
Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.
See all news